Home Tirzepatide cost
What Tirzepatide Costs in 2026: Every Path From $25 to $1,089 a Month
Insurance, savings cards, Medicare, manufacturer self-pay and compounded — priced honestly, with the twelve-month total for each.
Tirzepatide costs between $25 and $1,089 per month in the United States depending entirely on which route you qualify for. With commercial insurance that covers Zepbound, the manufacturer savings card can bring you to $25. On Medicare, the GLP-1 Bridge program is $50 for eligible Part D enrollees. Paying cash for FDA-approved product through LillyDirect runs $299–$449. Compounded tirzepatide from a licensed pharmacy runs $99–$299. Retail with no program applied is about $1,089.
The route you qualify for depends on your diagnoses and your insurance, not on your budget — so check eligibility before you assume you are a cash-pay patient.
On this page
Every route, priced
| Route | Monthly | Requires | FDA-approved |
|---|---|---|---|
| Mounjaro Savings Card | $25 | Type 2 diabetes diagnosis + commercial insurance covering Mounjaro | Yes |
| Zepbound Savings Card | $25 | Commercial insurance that covers Zepbound for weight management | Yes |
| Medicare GLP-1 Bridge | $50 | Part D enrollment + BMI/comorbidity tier; prescriber submits | Yes |
| Zepbound with coverage, no card | $30–$150 | Plan formulary placement; copay varies by tier | Yes |
| Compounded tirzepatide | $99–$299 | Telehealth prescription; no insurance involved | No |
| LillyDirect self-pay vials | $299–$449 | Prescription from your own clinician; price rises at 7.5 mg+ | Yes |
| Zepbound Savings Card, plan excludes weight loss | ≈$650 | Commercial insurance without weight-management coverage | Yes |
| Retail, no program | ≈$1,089 | Nothing | Yes |
If you have commercial insurance
Start by checking whether your plan covers Zepbound at all. Many employer plans carve out weight-management drugs entirely — that exclusion is what the $650 row above describes. The savings card only reaches $25 when the plan itself is paying most of the cost.
Two diagnoses change this conversation completely. If you have type 2 diabetes, Mounjaro is the on-label prescription and the Mounjaro savings card applies. If you have moderate-to-severe obstructive sleep apnea with obesity, Zepbound carries a specific FDA indication approved in December 2024 on the strength of SURMOUNT-OSA — and plans that exclude weight loss frequently do cover treatment for a diagnosed sleep disorder. If you snore heavily or wake unrefreshed, a sleep study is the highest-value thing on this page.
If you are denied, the denial is usually reversible. Our prior authorisation and appeal guide covers the four documentation gaps behind most first-pass denials and how a peer-to-peer review works.
If you are on Medicare
Federal law prohibits manufacturer copay assistance for Medicare and Medicaid beneficiaries, so the savings cards are unavailable regardless of income. The Medicare GLP-1 Bridge demonstration began dispensing on 1 July 2026 at a $50 monthly copay, covering Wegovy, Zepbound and Foundayo.
Eligibility is narrower than early coverage suggested: broadly a BMI of 35 or above, or 30 or above with heart failure, hypertension or chronic kidney disease, or 27 or above with prediabetes or a prior cardiovascular event. Your prescriber submits the request — you cannot do it yourself. Expect a turnaround measured in weeks.
If you are paying cash
You are choosing between FDA-approved product at $299–$449 and compounded product at $99–$299. That is not purely a price decision. Compounded medicines are not reviewed by FDA for safety, effectiveness or quality; the assurance rests on the compounding pharmacy and its state board. For many people the $700 monthly difference makes that trade obviously worthwhile. It should still be a decision you make knowingly.
Within the compounded market, the variable that matters most is whether pricing is flat or scales with dose. See the ranked comparison or run your own dose through the calculator.
The twelve-month view
Because SURMOUNT-4 showed 14% regain within a year of stopping, the realistic planning horizon is open-ended rather than a twelve-week course. Here is what a first year costs on each route, assuming four weeks at 2.5 mg, four weeks at 5 mg and ten months at 10 mg.
How this price is stated. All-in monthly price: medication plus any recurring membership or platform fee, at the stated dose tier, before tax and before any prepaid-term discount. Figures here are quoted at 10 mg. Prepaid rates and brand self-pay tiers are shown separately where they apply, never blended into the headline. Verified 2026-08-05. How we verify prices.
Every price on this site carries one of three verification levels, and they are not the same claim. 14 records are verified at source; 9 carry a third-party figure we have not confirmed with the provider; the rest publish no price at all.
- verified at source — Price read from the provider's own site, the manufacturer, or a named editorial source with a stated verification date.
- third-party figure — Price recorded from a third-party review supplied to us, not confirmed against the provider's own published material. Treat as indicative and confirm before enrolling.
- no price published — No figure we could interpret or verify. We publish nothing rather than estimate.
Levels are published per record in the open dataset. Where we verified a figure directly, seven times out of seven the correction changed the number.
| Program | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg | 12-month |
|---|---|---|---|---|---|---|---|
| IVIM Health dose-scaled | $208 | $231 | $255 | $278 | $302 | $325 | $3,219 |
| Oak Longevity flat pricing | $199 | $199 | $199 | $199 | $199 | $199 | $2,388 |
| Mochi Health flat pricing | $278 | $278 | $278 | $278 | $278 | $278 | $3,336 |
| ShedRx dose-scaled | $199 | $229 | $259 | $289 | $319 | $349 | $3,318 |
| NexLife flat pricing | $215 | $215 | $215 | $215 | $215 | $215 | $2,580 |
| bmiMD flat pricing | $233 | $233 | $233 | $233 | $233 | $233 | $2,796 |
| Eden dose-scaled | $348 | $368 | $388 | $408 | $428 | $448 | $4,796 |
| Join Fridays flat pricing | $249 | $249 | $249 | $249 | $249 | $249 | $2,988 |
| Yucca Health flat pricing | $258 | $258 | $258 | $258 | $258 | $258 | $3,096 |
| Direct Meds flat pricing | $280 | $280 | $280 | $280 | $280 | $280 | $3,360 |
| Zealthy flat pricing | $346 | $346 | $346 | $346 | $346 | $346 | $4,152 |
| SkinnyRx flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| LillyDirect (Zepbound) dose-scaled | $299 | $299 | $449 | $449 | $449 | $449 | $5,088 |
| MyStart Health flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Gala Health flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Sprout Health flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Willow flat pricing | $299 | $299 | $299 | $299 | $299 | $299 | $3,588 |
| Found flat pricing | $398 | $398 | $398 | $398 | $398 | $398 | $4,776 |
| Strut Health flat pricing | $325 | $325 | $325 | $325 | $325 | $325 | $3,900 |
| TrimRx flat pricing | $349 | $349 | $349 | $349 | $349 | $349 | $4,188 |
| OnlineSemaglutide.org flat pricing | $349 | $349 | $349 | $349 | $349 | $349 | $4,188 |
| MEDVi flat pricing | $399 | $399 | $399 | $399 | $399 | $399 | $4,788 |
| LifeMD flat pricing | $548 | $548 | $548 | $548 | $548 | $548 | $6,576 |
Costs nobody quotes you
Baseline labs. Some programs require a metabolic panel, HbA1c or kidney function before prescribing. That thoroughness is a good sign clinically, but ask whether it is billed to you.
Shipping and cold chain. Most tracked programs include refrigerated shipping. Confirm it, and confirm what happens if a package arrives warm.
Dose-change fees. Rare, but they exist. Ask.
Prepay lock-in. Six- and twelve-month plans typically save 15–30% per month, but compounded medication is almost never refundable once shipped. Prepay only after two months on a monthly plan, when you know you tolerate the drug.
Syringes and sharps disposal. Usually included with compounded vials; verify.
Frequently asked questions
How much does tirzepatide cost per month without insurance?
Compounded tirzepatide from licensed US telehealth programs runs roughly $99 to $299 per month depending on the provider and whether the price is flat or scales with your dose. Brand-name Zepbound through LillyDirect self-pay runs about $299 to $449 per month depending on strength. Retail Zepbound without any program is around $1,089.
Does insurance cover tirzepatide?
It depends on your plan and your diagnosis. Many commercial plans exclude weight-management drugs entirely. Zepbound carries a specific FDA indication for moderate-to-severe obstructive sleep apnea with obesity, and plans that exclude weight loss often cover a diagnosed sleep disorder. With type 2 diabetes, Mounjaro is on-label.
Can I use HSA or FSA funds for tirzepatide?
Generally yes for prescribed weight-management medication, including compounded products, though some plan administrators require a letter of medical necessity. Confirm with your administrator and keep every receipt.
Why do tirzepatide prices go up as my dose increases?
Because some programs price by dose tier rather than charging one rate. The advertised price usually reflects the 2.5 mg starter dose, which you occupy for about four weeks. Flat-rate programs charge the same amount at every dose. Over twelve months that structural difference typically matters more than any first-month discount.
What happens if I stop taking tirzepatide?
Weight regain is expected. In SURMOUNT-4, participants who switched to placebo after 36 weeks regained 14% of body weight over the following year, while those who continued lost a further 5.5%. Obesity behaves as a chronic condition and treatment is generally open-ended.
People also ask about tirzepatide cost
What is tirzepatide cost?
Tirzepatide cost is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.
Does tirzepatide cost apply to compounded tirzepatide as well as Zepbound?
The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.
How much does tirzepatide cost cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is tirzepatide cost FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.